To include your compound in the COVID-19 Resource Center, submit it here.

Infacort: Phase III final data

Final data from an open-label, German Phase III trial in 24 patients ages <6 with adrenal insufficiency

Read the full 173 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE